Amgen Inc.AMGNNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +10.86% | +9.43% | +9.29% | +12.40% | +8.91% |
| Gross Profit Growth | +17.51% | +21.99% | +19.49% | +24.69% | +35.69% |
| EBITDA Growth | -4.16% | +89.47% | +20.49% | +12.14% | +73.41% |
| Operating Income Growth | +81.83% | +18.87% | +38.50% | +23.40% | +70.58% |
| Net Income Growth | -18.25% | +0.00% | +91.96% | +13.64% | +112.60% |
| EPS Growth | -18.18% | +0.00% | +91.37% | +13.47% | +111.11% |
| EPS Diluted Growth | -18.31% | +0.00% | +92.03% | +13.60% | +111.21% |
| Weighted Average Shares Growth | +1.03% | +0.37% | +0.19% | +0.19% | -0.28% |
| Weighted Average Shares Diluted Growth | +0.37% | +0.93% | +0.00% | +0.00% | +0.18% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +786.80% | +101.89% | -7.28% | +31.17% | -66.40% |
| Free Cash Flow Growth | +1422.49% | +113.51% | -13.96% | +28.18% | -78.16% |
| Receivables Growth | -5.55% | +20.01% | +25.48% | +16.03% | +27.58% |
| Inventory Growth | -26.48% | -22.87% | -17.66% | -13.80% | -11.05% |
| Asset Growth | -5.47% | -3.89% | -3.31% | -0.82% | -1.36% |
| Book Value per Share Growth | -6.66% | +23.14% | +25.13% | +27.56% | +47.73% |
| Debt Growth | -6.99% | -10.37% | -10.28% | -9.62% | -9.14% |
| R&D Expense Growth | +12.39% | +10.65% | +20.53% | +31.03% | +24.77% |
| SG&A Expenses Growth | -17.41% | -6.69% | -5.27% | +5.85% | +3.14% |